These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Story behind the clinical trial of B.663 in leprosy. Chang YT Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040 [No Abstract] [Full Text] [Related]
26. [Lampren in the treatment of leprosy]. Ahrens T Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711 [No Abstract] [Full Text] [Related]
27. Primary dapsone-resistant leprosy in Cebu, Philippines. Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607 [TBL] [Abstract][Full Text] [Related]
28. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663). Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070 [No Abstract] [Full Text] [Related]
29. Treatment of leprosy with Lampren (B.663 Geigy). De las Aguas JT Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089 [No Abstract] [Full Text] [Related]
30. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy]. Renders A Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964 [No Abstract] [Full Text] [Related]
31. Clofazimine in leprosy. Schulz EJ Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339 [No Abstract] [Full Text] [Related]
32. The problem of dapsone-resistant leprosy. Pearson JM Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605 [No Abstract] [Full Text] [Related]